Home Page ::: Current Drug Targets

ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)


Volume 16, 14 Issues, 2015


Download PDF Flyer




Current Drug Targets

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 52nd of 254 in

    Pharmacology & Pharmacy


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Francis J. Castellino


Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.597
5 - Year: 3.558


Endorsement(s)

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Forthcoming Special Issue(s)

New Therapies, Markers and Therapeutic Targets in Hcv Chronic Infection, and Hcv Extrahepatic Manifestations


Guest Editor(s): Alessandro Antonelli, Mauro Pistello
Tentative Publication Date: December, 2015
Submit Abstract via Email Download Description
Published Special Issue(s)

By-Products As Scaffolds For Drug Delivery Systems: Design, Targeting Approaches, And Sustainability


Guest Editor(s): Luciano P Silva, Graziella A Joanitti
Download Description
Authors' Comments
We would like to express our gratitude to Bentham Science Publishers for the wonderful experience while working with the journal on this mini-thematic issue. There are several reasons for this enthusiasm.
We are grateful to the Editor-in-Chief, Dr Francis J. Castellino, for contacting us and offering us the chance to publish in Current Drug Targets, and accepting our proposal for a mini-thematic issue. It was a wonderful experience working with Shabana Seemee at the time of submission and processing of the papers. Shabana was always ready to support us whenever we had either a problem or a query.
We would like to acknowledge the high standard of all others who took care of editing and processing the papers to obtain the best final quality at the time of publication.
We would be delighted to continue to collaborate with the journal.

Dr. Rodolfo Montironi
Has contributed: Editorial Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers

Current Drug Targets

,

Volume 16

-

Number 4



CYLD-Mediated Signaling and Diseases

; Pp: 284 - 294

Bryan J. Mathis, Yimu Lai, Chen Qu, Joseph S. Janicki and Taixing Cui


DOI: 10.2174/1389450115666141024152421


Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy


Zhiyu Wang, Pengxi Liu, Qianjun Chen, Shigui Deng, Xiaoyan Liu, Honglin Situ, Shaowen Zhong, Swei Hann and Yi Lin


View Abstract Purchase Online

  
  


Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer


Caterina Marchiò, Davide Balmativola, Roberta Castiglione, Laura Annaratone and Anna Sapino


View Abstract Purchase Online

  
  


There is a Link between Erectile Dysfunction and Heart Failure: it Could be Inflammation


Fernanda Luciano Rodrigues, Rafael Sobrano Fais, Rita C. Tostes and Fernando S. Carneiro


View Abstract

  
  


Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer


Pavlos Msaouel, Jose Nahun Galeas, Alejandro Recio Boiles, Ramiro Rancier Ruiz and Michael Koutsilieris


View Abstract

  
  


Loop Diuretics Strategies in Acute Heart Failure: from Clinical Trials to Practical Application


Alberto Palazzuoli, Gaetano Ruocco, Marco Pellegrini, Matteo Beltrami, Gabriele Del Castillo and Ranuccio Nuti


View Abstract

  
  


AMP-activated protein kinase as a target for pathogens: friends or foes?


Diana Moreira, Ricardo Silvestre, Anabela Cordeiro-da-Silva, Jerome Estaquier, Marc Foretz and Benoit Viollet


View Abstract

  
  


Cancer Kinases and its novel inhibitors: Past, present and future challenges


Prathesha Pillai, Surenya.R.S, Shantikumar V Nair and Vinoth-Kumar Lakshmanan


View Abstract

  
  


Molecular Foundations for Personalized Therapy in Prostate Cancer

, 2015; 16(2): 103 - 114

Kurt W. Fisher, Rodolfo Montironi, Antonio Lopez Beltran, Holger Moch, Lisha Wang, Marina Scarpelli, Sean R. Williamson, Michael O. Koch and Liang Cheng


DOI: 10.2174/1389450115666141229154500
View Abstract Purchase Online Rights and Permissions

  
  


Affinity-Based Methods in Drug-Target Discovery

, 2015; 16(1): 60 - 76

Gabriela Rylova, Tomas Ozdian, Lakshman Varanasi, Miroslav Soural, Jan Hlavac, Dusan Holub, Petr Dzubak and Marian Hajduch


DOI: 10.2174/1389450115666141120110323
View Abstract Download Free Rights and Permissions

  
  


Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells

, 2014; 15(14): 1331 - 1340

Leticia G. Leon, Maria Gemelli, Rocco Sciarrillo, Amir Avan, Niccola Funel and Elisa Giovannetti


DOI: 10.2174/1389450116666141205160924
View Abstract Purchase Online Rights and Permissions

  
  


Targeting SUMOylation Cascade for Diabetes Management

, 2014; 15(12): 1094 - 1106

Dornadula Sireesh, Elango Bhakkiyalakshmi, Kunka Mohanrama Ramkumar, Shanmugakani Rathinakumar, Panneer Selvam Anto Jennifer, Palanisamy Rajaguru and Ramasamy Paulmurugan


DOI: 10.2174/1389450115666140915124747
View Abstract Purchase Online Rights and Permissions

  
  


Advertisement

Related Journals




Related eBooks




Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science